<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Virology</title>
<title_fa>مجله ویروس شناسی ایران</title_fa>
<short_title>Iran J Virol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.isv.org.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1735-5680</journal_id_issn>
<journal_id_issn_online>2588-5030</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.21859/isv</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1394</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2015</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<volume>9</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Serum and Urine Level of IP-10 in Patients with HCV infection Based on Clinical and Virological Markers</title>
	<subject_fa>عمومى</subject_fa>
	<subject>General</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div&gt;
&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Background and Aims:&lt;/strong&gt; IP-10 molecule is a new biomarker to predict response to treatment in chronic HCV infection. Also urine IP-10 has been suggested as a biomarker in other infections. But already, it has low data in urine as well as serum level of IP-10 for HCV infection. The aim of this study was to assess urine and serum level of IP-10 in patients with type 1 and 3a HCV infection.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Materials and Methods:&lt;/strong&gt; In this case-control study, 105 patients with HCV infection were involved in three 35 people groups. Blood and urine sample of all patients was collected to determine IP-10 level. Finally, data analysis was reported using SPSS, mean statistics analysis and T test.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Results:&lt;/strong&gt; The age mean was 41.6&amp;plusmn;11.2 ranging 21-68. Urine and serum level of IP-10 in patient group was significantly higher than control (p=0.001). Serum level of IP-10 based on HCV genotype was higher significantly in genotype 1a than 3a (p=0.001) but there was no significant difference of urine IP-10 level between genotypes 1a and 3a.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The results show IP-10 is a proper marker to determine the prognosis of fibrosis and progress liver inflammation and on the other hand, the prediction of response to treatment differs in various genotypes of HCV infection.&lt;/p&gt;
&lt;/div&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Hepatitis C, IP-10, serum and urine, genotype 3a and 1a</keyword>
	<start_page>1</start_page>
	<end_page>8</end_page>
	<web_url>http://journal.isv.org.ir/browse.php?a_code=A-10-78-3&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Zahra</first_name>
	<middle_name></middle_name>
	<last_name>Moallemi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ahvasmehjani@gmail.com</email>
	<code>10031947532846003135</code>
	<orcid>10031947532846003135</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Associate Professor, Infectious and Tropical Diseases Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Jamshid</first_name>
	<middle_name></middle_name>
	<last_name>Ayatollahi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>a.ahmadi.tums.ac@gmail.com</email>
	<code>10031947532846003136</code>
	<orcid>10031947532846003136</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Associate Professor, Infectious and Tropical Diseases Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Masoud</first_name>
	<middle_name></middle_name>
	<last_name>Doosti</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>m.doosti58@gmail.com</email>
	<code>10031947532846003137</code>
	<orcid>10031947532846003137</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Associate Professor, Infectious and Tropical Diseases Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
